Gut Microbiota and Bile Acids Mediate the Clinical Benefits of YH1 in Male Patients with Type 2 Diabetes Mellitus: A Pilot Observational Study.

Pharmaceutics · 2022 · PMC9505101 · PMID 36145605

Europe PMC DOI

hedged sentences

0.0700

closest p · 1.4× alpha

0.0700

boldest claim

The sentences

a decreasing trendp = 0.07so close (0.05 < p ≤ 0.1)

Levels of the liver enzyme alanine aminotransferase (ALT) showed a decreasing trend after YH1 treatment ( p = 0.07), with a median decrease from 49.5 to 39.5 U/L.

also in 47,180 other papers

highly significantno p-value reported

Values of p < 0.05 (*) were considered statistically significant, and p < 0.01 (**) was considered highly significant. 3.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.